Quality-controlled characterization of a monoclonal antibody specific to an EC5-domain of human desmoglein 3 for pemphigus research
Rüdiger Eming(Philipps University of Marburg), Christoph Hudemann(Philipps University of Marburg), Eliane J. Müller(University of Bern), Ritva Tikkanen(Justus-Liebig-Universität Gießen), Christine L. Zimmer(Philipps University of Marburg), Anna Zakrzewicz(Justus-Liebig-Universität Gießen), Shafaq Riaz(Philipps University of Marburg), Uwe Linne(Philipps University of Marburg)
Cited by 1
Related Papers
Diagnosis and management of pemphigus: Recommendations of an international panel of experts
|Journal of the American Academy of Dermatology|2018|384
Membrane and raft association of reggie-1/flotillin-2: role of myristoylation, palmitoylation and oligomerization and induction of filopodia by overexpression
|Biochemical Journal|2004|260
Long-Term Remissions of Severe Pemphigus After Rituximab Therapy Are Associated with Prolonged Failure of Desmoglein B Cell Response
|Science Translational Medicine|2013|246
Pemphigus: Current and Future Therapeutic Strategies
|Frontiers in Immunology|2019|245
Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls.
|Journal of Clinical Investigation|1998|235